Visumab 0.5mg Injection

Visumab 0.5 mg Injection – Ranibizumab for Retinal Eye Disorders

Visumab 0.5 mg Injection contains Ranibizumab 0.5 mg, a prescription anti-VEGF ophthalmic medicine used to treat selected retinal conditions involving abnormal blood-vessel growth, fluid leakage, or swelling inside the eye. Ranibizumab works by blocking vascular endothelial growth factor, also known as VEGF. VEGF contributes to the formation and leakage of abnormal blood vessels in the retina, which may lead to retinal swelling, blurred vision, and progressive vision loss. Visumab 0.5 mg Injection must be administered only by a qualified ophthalmologist experienced in intravitreal injections. The treatment frequency and duration depend on the diagnosed retinal condition and the ophthalmologist’s treatment plan.

Key Features

• Contains Ranibizumab 0.5 mg: An anti-VEGF monoclonal antibody fragment.
• Retinal Eye Treatment: Used for selected disorders involving retinal swelling and abnormal blood vessels.
• Reduces Vascular Leakage: Helps control fluid leakage and swelling within the retina.
• Intravitreal Injection: Administered directly into the vitreous cavity of the eye.
• Specialist Administration: Must be prepared and injected by a trained ophthalmologist.
• Cold-Chain Medicine: Requires refrigerated storage and must not be frozen.

Active Ingredient

• Ranibizumab 0.5 mg: An anti-VEGF medicine that helps reduce abnormal retinal blood-vessel growth, vascular leakage, and retinal swelling.

Uses

• Neovascular or wet age-related macular degeneration.
• Diabetic macular edema and selected diabetic retinal conditions.
• Macular edema following retinal vein occlusion.
• Other retinal conditions involving abnormal blood vessels when specifically diagnosed by an ophthalmologist.

How It Is Administered

• Visumab must be administered only by a qualified ophthalmologist.
• It is given as an intravitreal injection directly into the affected eye.
• It must not be self-administered or injected into a vein, muscle, or under the skin.
• The ophthalmologist will determine the appropriate dose and treatment schedule.
• Strict sterile and aseptic techniques must be followed during preparation and administration.
• Each injection presentation is intended for single use only.
• Any unused solution must be discarded according to appropriate medical-waste procedures.

Warning

• Serious Eye Infection: Intravitreal injections may cause endophthalmitis, a potentially sight-threatening infection inside the eye.
• Retinal Complications: Retinal tear, retinal detachment, inflammation, bleeding, or traumatic cataract may occur.
• Increased Eye Pressure: Pressure inside the eye may increase after administration.
• Seek immediate medical attention for increasing eye pain, redness, blurred or reduced vision, increased floaters, or unusual sensitivity to light.
• Temporary visual disturbances may occur following the injection.
• Avoid driving or operating machinery until vision becomes clear.

Possible Side Effects

• Eye pain, irritation, itching, or discomfort.
• Eye redness or bleeding on the surface of the eye.
• Temporary blurred vision.
• Floaters or a foreign-body sensation in the eye.
• Dry eye or increased tearing.
• Inflammation inside the eye.
• Increased pressure inside the eye.
• Eyelid inflammation.
• Headache or joint discomfort.

Storage

• Store in a refrigerator between 2°C and 8°C.
• Do not freeze.
• Keep the product in its original packaging to protect it from light.
• Do not shake the injection.
• Do not use if the solution appears cloudy, discoloured, or contains visible particles.
• Do not use if the vial, syringe, seal, or packaging is opened, damaged, or tampered with.
• Do not use after the expiry date printed on the packaging.
• Keep out of reach of children and unauthorized individuals.

Legal Disclaimer: Visumab 0.5 mg Injection is a prescription ophthalmic biological medicine intended exclusively for intravitreal administration by a qualified ophthalmologist. It may cause serious eye-related adverse reactions. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, treatment, or the official instructions supplied with the medicine.